Patents Assigned to Epalex Corporation
  • Fospropofol methods and compositions
    Patent number: 11628178
    Abstract: The present disclosure pertains to the use of fospropofol, pharmaceutically acceptable salts of fospropofol, or mixtures thereof. Pharmaceutical compositions comprising fospropofol, pharmaceutically acceptable salts of fospropofol, or mixtures thereof, and methods of treating diseases or disorders, including migraine are also disclosed.
    Type: Grant
    Filed: March 4, 2022
    Date of Patent: April 18, 2023
    Assignee: Epalex Corporation
    Inventors: Steven L. Krill, Feng-Jing Chen, Michael A. Rogawski, Edward Brendan Magrab, Allen H. Heller
  • Fospropofol salts, methods and compositions
    Patent number: 11547714
    Abstract: The present disclosure pertains to pharmaceutically acceptable salts of fospropofol and their use to treat migraine.
    Type: Grant
    Filed: February 5, 2021
    Date of Patent: January 10, 2023
    Assignee: EPALEX CORPORATION
    Inventors: Randall B. Murphy, Steven L. Krill, Samuel Andrew
  • Fospropofol formulations
    Patent number: 11478490
    Abstract: The present disclosure provides pharmaceutical compositions for oral administration of fospropofol, or pharmaceutically acceptable salts of fospropofol, as well as methods of oral administration of fospropofol.
    Type: Grant
    Filed: July 28, 2021
    Date of Patent: October 25, 2022
    Assignee: Epalex Corporation
    Inventors: Steven L. Krill, Feng-Jing Chen
  • Fospropofol formulations
    Patent number: 11439653
    Abstract: The present disclosure provides pharmaceutical compositions for oral administration of fospropofol, or pharmaceutically acceptable salts of fospropofol, as well as methods of oral administration of fospropofol.
    Type: Grant
    Filed: September 3, 2021
    Date of Patent: September 13, 2022
    Assignee: EPALEX CORPORATION
    Inventors: Steven L. Krill, Feng-Jing Chen
  • Fospropofol formulations
    Patent number: 11207334
    Abstract: The present disclosure provides pharmaceutical compositions for oral administration of fospropofol, or pharmaceutically acceptable salts of fospropofol, as well as methods of oral administration of fospropofol.
    Type: Grant
    Filed: March 30, 2021
    Date of Patent: December 28, 2021
    Assignee: Epalex Corporation
    Inventors: Steven L. Krill, Feng-Jing Chen